期刊文献+

非酒精性脂肪性肝病对糖尿病患者胰岛功能的影响 被引量:13

The impact of non-alcoholic fatty liver disease on islet function in type 2 diabetes
原文传递
导出
摘要 目的 评价非酒精性脂肪性肝病(NAFLD)对于糖尿病患者胰岛功能的影响.方法 采用回顾性分析方法,纳入213例天津医科大学代谢病医院2013年1-12月住院的2型糖尿病(T2DM)患者,根据有无NAFLD分为T2DM合并NAFLD组和单纯T2DM组;所有患者均检测ALT、AST、γ-谷氨酰转肽酶(γ-GT)、血脂、糖化血红蛋白(HbA1c)、果糖胺、空腹血糖、空腹胰岛素及糖负荷后2h血糖、胰岛素;采用稳态模型评估法计算胰岛素抵抗指数(HOMA-IR)和胰岛β细胞功能指数(HOMA-β)用于评价胰岛素抵抗和胰岛β细胞功能.结果 T2DM患者NAFLD发生率为51%(即T2DM合并NAFLD患者108例);T2DM合并NAFLD组和单纯T2DM组血糖水平、HbA1c和果糖胺水平差异无统计学意义(P>0.05),T2DM合并NAFLD组HOMA-IR和HOMA-β明显高于单纯T2DM组[分别为4.76(2.83,7.21)比2.79(1.76,4.37),P<0.05和49.18(37.78,85.09)比29.50(18.09,45.54),P<0.05];T2DM合并NAFLD组中,肝功能正常组HOMA-IR、HOMA-β明显高于肝功能异常组[分别为6.28(2.87,8.17)比2.95(2.07,3.66)和59.18(37.78,85.09)比30.59(28.56,34.49),P值均<0.05].结论 T2DM患者合并NAFLD时,肝功能正常阶段,胰岛素抵抗较明显,胰岛β细胞功能代偿性升高;若肝功能发生异常,胰岛β细胞功能减退较明显. Objective To analyze the influence of hepatosteatosis on pancreatic β-cell function in type 2 diabetes mellitus (T2DM).Methods A total of 213 subjects with T2DM from Metabolic Disease Hospital,Tianjin Medical University from January 2013 to December 2013 were included in the study.Non-alcoholic fatty liver disease (NAFLD) was diagnosed with abdominal ultrasonography.Patients were divided into two groups:T2DM with NAFLD and T2DM without NAFLD.ALT,AST,γ-glutamyltransferase,serum lipid,glycosylated hemoglobin A1 c (HbA1c),fructosamine,fasting glucose,insulin and 2 hours plasma glucose,insulin after 75g glucoseload were detected.The insulin resistance and β-cell function were assessed by HOMA-IR and HOMA-β.Results Among the 213 T2DM subjects,51% (108 cases) were with NAFLD.The HOMA-IR [4.76 (2.83,7.21) vs 2.79 (1.76,4.37),P 〈 0.05] and HOMA-β [49.18 (37.78,85.09) vs 29.50 (18.09,45.54),P 〈 0.05] were significantly higher in T2DM with NAFLD than those in T2DM alone.Within subjects with T2DM and NAFLD,the HOMA-IR [6.28 (2.87,8.17) vs 2.95 (2.07,3.66) P 〈 0.05] and HOMA-β [59.18 (37.78,85.09) vs 30.59 (28.56,34.49),P 〈 0.05] levels were higher in subjects with normal liver function than those with abnormal liver function.Conclusions T2DM patients with NAFLD have severer insulin resistance than those without NAFLD.The β-cell function of those patients was compensatory increased,which was decreased in subjects with abnormal liver function.
出处 《中华内科杂志》 CAS CSCD 北大核心 2015年第3期197-200,共4页 Chinese Journal of Internal Medicine
关键词 糖尿病 2型 脂肪肝 非酒精性 胰岛素抗药性 Fatty liver,non-alcoholic disease Insulin resistance
  • 相关文献

参考文献21

  • 1De Alwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears[J]. J Hepatol, 2008, 48(Suppl 1): S104-S112.
  • 2Akbar DH, Kawther AH. Nonalcoholic fatty liver disease in Saudi type 2 diabetic subjects attending a medical outpatient clinic: prevalence and general characteristics[J]. Diabetes Care, 2003, 26(12): 3351-3352.
  • 3Gupte P, Amarapurkar D, Agal S, et al. Non-alcoholic steatohepatitis in type 2 diabetes mellitus[J].J Gastroenterol Hepatol, 2004, 19(8):854-858.
  • 4Fruci B, Giuliano S, Mazza A, et al. Nonalcoholic fatty liver: a possible new target for type 2 diabetes prevention and treatment[J].Int J Mol Sci, 2013, 14(11):22933-22966.
  • 5Bugianesi E, Gastaldelli A, Vanni E, et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms[J].Diabetologia, 2005, 48(4):634-642.
  • 6Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity[J].Gastroenterology, 1999, 116(6):1413-1419.
  • 7Martín-Domínguez V, González-Casas R, Mendoza-Jiménez-Ridruejo J, et al. Pathogenesis, diagnosis and treatment of non-alcoholic fatty liver disease[J]. Rev Esp Enferm Dig, 2013, 105(7):409-420.
  • 8杨文英.非酒精性脂肪肝是胰岛素抵抗的早期标志[J].中华内科杂志,2007,46(3):177-178. 被引量:25
  • 9Wang Y, Li YY, Nie YQ, et al. Association between metabolic syndrome and the development of non-alcoholic fatty liver disease[J].Exp Ther Med, 2013, 6(1):77-84.
  • 10Utzschneider KM, Kahn SE. Review: The role of insulin resistance in nonalcoholic fatty liver disease[J].J Clin Endocrinol Metab, 2006, 91(12):4753-4761.

二级参考文献20

  • 1杨文英,邢小燕,林红,马晓华,胡英华,李光伟,潘孝仁.高甘油三酯血症是非胰岛素依赖型糖尿病发病的危险因素──432例非糖尿病人群六年前瞻性观察[J].中华内科杂志,1995,34(9):583-586. 被引量:143
  • 2Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1513
  • 3颜红梅,高鑫,刘蒙,顾迁,张斌,李湘,高键,赵耐青.非酒精性脂肪肝与代谢综合征关系的研究[J].中国糖尿病杂志,2006,14(5):326-328. 被引量:74
  • 4陈晓平,杨文英,萧建中,潘琳,卜石.马来酸罗格列酮干预高脂饲养大鼠脂肪肝的研究[J].中国糖尿病杂志,2006,14(5):380-382. 被引量:10
  • 5Marchesini G,Bugiansi E,Forlani G,et al.Nonalcoholic fatty liver,steatohepatitis,and the metabolic syndrome.Hepatology,2003,37:917-923.
  • 6Nannipieri M,Haffner SM,Ferrannini E,et al.Liver enzymes,the metabolic syndrome and incident diabetes:the mexico city Diabetes Study.Diabetes Care,2005,28:1757-1762.
  • 7Schindhelm RK,Diamant M,Bakker SJL,et al.Liver alanine aminotransferase,insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus.Eur J Clin Invest,2005,35:369-374.
  • 8Hanley AJ,Williams K,Haffner SM,et al.Elevations in markers of liver injury and risk of type 2 diabetes the insulin resistance atherosclerosis Study.Diabetes,2004,53:2623-2632.
  • 9Dixon JB,Bhathal PS,O' Brien PE.Nonalcoholic fatty liver disease:predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.Gastroenterology,2001,121:91-100.
  • 10Expert panel on detection,evaluation,and treatment of high blood cholesterol in adults.Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ).JAMA,2001,285:2486-2497.

共引文献44

同被引文献102

引证文献13

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部